Company performance
Current Price
as of Jan 06, 2025$33.54
P/E Ratio
2.95
Market Cap
$1.91B
Loading...
Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAGIO
- Price$33.54+4.19%
Trading Information
- Market cap$1.91B
- Float96.68%
- Average Daily Volume (1m)1,306,599
- Average Daily Volume (3m)821,730
- EPS$11.79
Company
- Revenue$32.87M
- Rev growth (1yr)21.15%
- Net income$947.92M
- Gross margin76.26%
- EBITDA margin-1,131.93%
- EBITDA-$101.47M
- EV$1.65B
- EV/Revenue50.26
- P/E2.95
- P/S59.62
- P/B1.18
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset